Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
Author:
Funder
IFN
Gilead Sciences
Publisher
Elsevier BV
Subject
General Medicine
Reference40 articles.
1. A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan;Bennett;Hepatol Int,2015
2. Global epidemiology and genotype distribution of the hepatitis C virus infection;Gower;J Hepatol,2014
3. Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa;Liu;Int J Nanomed,2014
4. Huge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan;Yu;Medicine (Baltimore),2015
5. APASL consensus statements and recommendation on treatment of hepatitis C;Omata;Hepatol Int,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Policy and Strategy for Hepatitis C Virus Elimination at the National Level: Experience in Taiwan;The Journal of Infectious Diseases;2023-09-13
2. Taiwan accelerates its efforts to eliminate hepatitis C;Global Health & Medicine;2021-10-31
3. Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan;Journal of the Formosan Medical Association;2020-12
4. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population;Journal of the Formosan Medical Association;2020-06
5. Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma;PLOS ONE;2020-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3